(Q43257763)

English

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

scientific article published in December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 November 2017

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin (English)

1 reference

Europe PubMed Central

17 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peginterferon alfa-2a

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Manuel Romero-Gómez

1

1 reference

Europe PubMed Central

17 November 2017

Moisés Diago

2

1 reference

Europe PubMed Central

17 November 2017

Raúl J Andrade

3

1 reference

Europe PubMed Central

17 November 2017

José L Calleja

4

1 reference

Europe PubMed Central

17 November 2017

Javier Salmerón

5

1 reference

Europe PubMed Central

17 November 2017

Conrado M Fernández-Rodríguez

6

1 reference

Europe PubMed Central

17 November 2017

Ricard Solà

7

1 reference

Europe PubMed Central

17 November 2017

Javier García-Samaniego

8

1 reference

Europe PubMed Central

17 November 2017

Juan M Herrerías

9

1 reference

Europe PubMed Central

17 November 2017

Manuel De la Mata

10

1 reference

Europe PubMed Central

17 November 2017

Ricardo Moreno-Otero

11

1 reference

Europe PubMed Central

17 November 2017

Oscar Nuñez

12

1 reference

Europe PubMed Central

17 November 2017

Antonio Olveira

13

1 reference

Europe PubMed Central

17 November 2017

Santiago Durán

14

1 reference

Europe PubMed Central

17 November 2017

Ramón Planas

15

1 reference

Europe PubMed Central

17 November 2017

Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group

16

1 reference

Europe PubMed Central

17 November 2017

language of work or name

0 references

publication date

1 December 2009

1 reference

Europe PubMed Central

17 November 2017

1 reference

Europe PubMed Central

17 November 2017

50

1 reference

Europe PubMed Central

17 November 2017

6

1 reference

Europe PubMed Central

17 November 2017

1702-1708

1 reference

Europe PubMed Central

17 November 2017

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Hepatitis C virus infection: molecular pathways to metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Involvement of endoplasmic reticulum stress in insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Effect of vitamin K supplementation on insulin resistance in older men and women

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Addition of metformin to a lifestyle modification program in adolescents with insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Weight changes in type 2 diabetes and the impact of gender

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Cancer risks in LKB1 germline mutation carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

21 January 2018

Insulin resistance as a non-invasive method for the assessment of fibrosis in patients with hepatitis C: a comparative study of biochemical methods

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23206

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23206

1 reference

Europe PubMed Central

17 November 2017

1 reference

Europe PubMed Central

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43257763&oldid=1985030602"